Otonomy · Small Molecule · Phase 2
DiscontinuedTherapeutic
Population
Adults · 18–75 years
Persistent unilateral cochlear tinnitus
Evidence
company
Confidence
96%
Indications
Tinnitus
Therapies database
Find a therapy. Follow the evidence.
See what is being studies, who is developing it, and how far it has progressed.
Search therapy records
Search a therapy, company, target, indication, or trial ID. Narrow by approach, stage, or status, then open a record to check its sources.
More filters and sort (2 active)
3 results
Otonomy · Biologic · Phase 2
DiscontinuedTherapeutic
Population
Adults · 21–64 years
Speech-in-noise hearing impairment
Evidence
company
Confidence
95%
Indications
Hearing LossSensorineural Hearing LossHidden Hearing LossCochlear Synaptopathy
Otonomy · Gene Therapy · Preclinical
DiscontinuedTherapeutic
Population
Children & adults · Not yet defined (preclinical)
Congenital GJB2-deficient hearing loss
Evidence
company
Confidence
87%
Indications
Hearing LossSensorineural Hearing LossGenetic Hearing Loss
A listing is not proof of safety or effectiveness. Approval and availability may vary by indication and country.
How records are checked